Log in
Enquire now

List of SBIR/STTR awards granted to CENGENT THERAPEUTICS, INC.

List of SBIR/STTR awards granted to CENGENT THERAPEUTICS, INC.
List of SBIR/STTR awards granted to MV Innovative Technologies LLC (DBA: Opt
List of SBIR/STTR awards granted to HOUSTON PHARMECUTICAL INC
List of SBIR/STTR awards granted to Dayton T. Brown, Inc.
List of Cyberonics patents
List of funding rounds for Nasuni
where
SBIR/STTR Award Recipient
is
‌
CENGENT THERAPEUTICS, INC.
Name
Description
SBIR/STTR Award Recipient
Government Agency
Government Branch
Award Type
Contract Number (US Government)
Award Phase
Award Amount (USD)
Date Awarded
Official Website
‌
CENGENT THERAPEUTICS, INC. SBIR Phase II Award,

A SBIR Phase II contract was awarded to CENGENT THERAPEUTICS, INC. for $754,259.0 USD from the U.S. Department of Health & Human Services.

‌
CENGENT THERAPEUTICS, INC.
SBIR
2R44AI045237-02A1
Phase II
754,259
sbir.gov/content/non-peptides-inhibitors-anthrax-lethal-factor-0
‌
CENGENT THERAPEUTICS, INC. SBIR Phase I Award,

A SBIR Phase I contract was awarded to CENGENT THERAPEUTICS, INC. for $99,688.0 USD from the U.S. Department of Health & Human Services.

‌
CENGENT THERAPEUTICS, INC.
SBIR
1R43CA101580-01
Phase I
99,688
sbir.gov/content/design-small-molecule-antagonists-egf-egfr-binding-0
‌
CENGENT THERAPEUTICS, INC. SBIR Phase I Award,

A SBIR Phase I contract was awarded to CENGENT THERAPEUTICS, INC. from the U.S. Department of Health & Human Services.

‌
CENGENT THERAPEUTICS, INC.
SBIR
2R44AI045237-02A1
Phase I
0
sbir.gov/content/non-peptides-inhibitors-anthrax-lethal-factor-2
‌
CENGENT THERAPEUTICS, INC. SBIR Phase I Award,

A SBIR Phase I contract was awarded to CENGENT THERAPEUTICS, INC. for $99,297.0 USD from the U.S. Department of Health & Human Services.

‌
CENGENT THERAPEUTICS, INC.
SBIR
1R43AI060248-01
Phase I
99,297
sbir.gov/content/structure-based-design-bacterial-gtpase-inhibitors-0
‌
CENGENT THERAPEUTICS, INC. SBIR Phase I Award,

A SBIR Phase I contract was awarded to CENGENT THERAPEUTICS, INC. for $100,000.0 USD from the U.S. Department of Health & Human Services.

‌
CENGENT THERAPEUTICS, INC.
SBIR
Phase I
100,000
sbir.gov/content/not-available-2584
‌
CENGENT THERAPEUTICS, INC. SBIR Phase II Award,

A SBIR Phase II contract was awarded to CENGENT THERAPEUTICS, INC. for $372,652.0 USD from the U.S. Department of Health & Human Services.

‌
CENGENT THERAPEUTICS, INC.
SBIR
Phase II
372,652
sbir.gov/content/small-molecule-drug-specific-her2-inhibition-2
‌
CENGENT THERAPEUTICS, INC. SBIR Phase I Award,

A SBIR Phase I contract was awarded to CENGENT THERAPEUTICS, INC. from the U.S. Department of Health & Human Services.

‌
CENGENT THERAPEUTICS, INC.
SBIR
Phase I
0
sbir.gov/content/small-molecule-drug-specific-her2-inhibition-0
‌
CENGENT THERAPEUTICS, INC. SBIR Phase II Award,

A SBIR Phase II contract was awarded to CENGENT THERAPEUTICS, INC. for $315,334.0 USD from the U.S. Department of Health & Human Services.

‌
CENGENT THERAPEUTICS, INC.
SBIR
Phase II
315,334
sbir.gov/content/structure-based-design-novel-interleukin-5-receptor-0
‌
CENGENT THERAPEUTICS, INC. SBIR Phase I Award,

A SBIR Phase I contract was awarded to CENGENT THERAPEUTICS, INC. from the U.S. Department of Health & Human Services.

‌
CENGENT THERAPEUTICS, INC.
SBIR
Phase I
0
sbir.gov/content/structure-based-design-novel-interleukin-5-receptor-2
9 results
0 selected
9 results
0 selected
Golden logo

Company

  • Home
  • Pricing
  • Become an Editor
  • Enterprise

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us

Explore companies

  • Artificial Intelligence
  • Fintech
  • Biotechnology
  • Cybersecurity
  • Semiconductors
  • Electric Vehicles
  • Cloud Computing
  • Robotics
  • SaaS
  • Renewable Energy
  • Venture Capital
  • Blockchain
  • Browse all →